- Home
- SAVA vs SEVN Comparison
SAVA vs SEVN Comparison
Compare SAVA & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- SEVN
- Stock Information
- Founded
- SAVA 1998
- SEVN 1986
- Country
- SAVA United States
- SEVN United States
- Employees
- SAVA N/A
- SEVN N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- SEVN Real Estate Investment Trusts
- Sector
- SAVA Health Care
- SEVN Real Estate
- Exchange
- SAVA Nasdaq
- SEVN Nasdaq
- Market Cap
- SAVA 157.5M
- SEVN 135.0M
- IPO Year
- SAVA N/A
- SEVN N/A
- Fundamental
- Price
- SAVA $2.82
- SEVN $8.65
- Analyst Decision
- SAVA Buy
- SEVN Strong Buy
- Analyst Count
- SAVA 2
- SEVN 2
- Target Price
- SAVA $5.00
- SEVN $13.50
- AVG Volume (30 Days)
- SAVA 1.2M
- SEVN 211.2K
- Earning Date
- SAVA 11-12-2025
- SEVN 10-27-2025
- Dividend Yield
- SAVA N/A
- SEVN 12.92%
- EPS Growth
- SAVA N/A
- SEVN N/A
- EPS
- SAVA N/A
- SEVN 1.04
- Revenue
- SAVA N/A
- SEVN $29,408,000.00
- Revenue This Year
- SAVA N/A
- SEVN N/A
- Revenue Next Year
- SAVA N/A
- SEVN N/A
- P/E Ratio
- SAVA N/A
- SEVN $8.36
- Revenue Growth
- SAVA N/A
- SEVN N/A
- 52 Week Low
- SAVA $1.15
- SEVN $8.62
- 52 Week High
- SAVA $33.98
- SEVN $13.97
- Technical
- Relative Strength Index (RSI)
- SAVA 38.79
- SEVN 27.36
- Support Level
- SAVA $2.65
- SEVN $8.62
- Resistance Level
- SAVA $3.30
- SEVN $10.90
- Average True Range (ATR)
- SAVA 0.21
- SEVN 0.23
- MACD
- SAVA -0.07
- SEVN -0.04
- Stochastic Oscillator
- SAVA 18.02
- SEVN 4.79
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.